We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
- Authors
Tung, B Y; Emond, M J; Haggitt, R C; Bronner, M P; Kimmey, M B; Kowdley, K V; Brentnall, T A
- Abstract
Patients with ulcerative colitis and primary sclerosing cholangitis are at high risk for colonic dysplasia and cancer. This risk approaches 50% after 25 years of colitis. Ursodiol has been shown to protect against development of colorectal neoplasia in animal models.
- Publication
Annals of internal medicine, 2001, Vol 134, Issue 2, p89
- ISSN
0003-4819
- Publication type
Journal Article
- DOI
10.7326/0003-4819-134-2-200101160-00008